We use your sign-up to provide content in ways you’ve consented to and to improve our understanding of you. This may include adverts from us and 3rd parties based on our understanding. You can unsubscribe at any time. More info
A committee of independent advisers for the Food and Drugs Administration has voted in favour of authorising a booster dose of Pfizer/BioNTech after rejecting Pfizer’s applications to distribute booster shots to the wider population. The panel has unanimously embraced the alternate plane to offer booster shots to older Americans and other vulnerable people at risk of severe illness, at least six month after completion of the primary two doses.
The panel’s recommendation comes as President Joe Biden’s administration has said it wants to begin offering booster shots to the general public as early as next week.
Doctor Ofer Levy, a vaccine and infectious disease specialist at Boston’s Children’s Hospital, said: “It’s likely beneficial in my opinion for the elderly, and may eventually be indicated for the general population.
“I just don’t think we’re there yet in terms of the data.”
The meeting came days after a group of leading researchers suggested vaccine protection against severe Covid persists despite protection against mild disease waning over time.
Source: Read Full Article
